Jonathan Sherman

Jonathan Sherman
Telephone: 416 869 5409
Fax: 416 640 3136

Suite 2100, Scotia Plaza
40 King Street West
Toronto, ON M5H 3C2

Download vCard

“Earns high praise for his involvement in the cannabis sector, ‘with this expertise at hand, the business end of things then takes care of itself.’”
– Client Testimonial, Chambers Canada

Jonathan Sherman is a partner in our Business Law Group and Securities Group. Jonathan is also co-chair of the firm's Cannabis Group, one of only two Canadian law firms recognized as a Band 1 firm in cannabis by Chambers Canada. Jonathan was recognized as a leading practitioner in the cannabis sector by Chambers Canada.

Jonathan is routinely retained to act on behalf of a wide variety of cannabis industry participants, including: licensed and pre-licensed cultivators, processors and retailers in Canada, the United States and other international jurisdictions; pharmaceutical, beverage and consumer goods companies seeking opportunities to participate in the emerging global cannabis sector; and other ancillary businesses providing goods and services to the cannabis industry. As the cannabis sector continues to evolve, Jonathan is at the forefront of many of the largest industry transactions, providing strategic and legal advice to a range of leading industry players on complex and innovative transactions. His corporate clients range in size and stage from start-ups to multi-billion dollar businesses. 

Jonathan’s practice has an emphasis on mergers and acquisitions and corporate finance transactions. His M&A practice involves various public and private acquisitions, business combinations, joint ventures, go-public transactions and strategic collaborations. Jonathan’s corporate finance experience includes public offerings, venture capital, private equity offerings, as well as debt financing transactions. He also regularly advises public, private, domestic and international clients on a broad range of complex corporate, commercial and securities matters, including supply arrangements, partnership agreements, licensing and royalty transactions and various other corporate governance matters.

Whether strategically guiding clients through M&A, or helping emerging start-ups secure investments, Jonathan has been a trusted advisor in many of the largest transactions completed to-date in the nascent cannabis industry, including advising Canopy Growth on: their listing as the first ever cannabis company on the New York Stock Exchange; over $1 billion of M&A transactions; the $600 million offering of senior convertible unsecured notes, the largest convertible debt financing to-date completed by a company listed on a Canadian stock exchange; the joint venture, licensing and development of the largest cannabis production facility in the world; and various supply and processing arrangements involving, among others, MediPharm Labs, 48North, Radicle Cannabis, James E. Wagner Cultivation, Neptune Technologies & Bioressources and Centric Health.

Jonathan has advised Canopy Rivers on: its listing on the TSX Venture Exchange and concurrent $104 million offering, the first go-public transaction completed by a company in the cannabis industry to be led by a Schedule 1 bank; and various venture capital transactions, including, among others, Canopy Rivers’ investments in TerrAscend, Radicle Cannabis, James E. Wagner Cultivation, LiveWell, Civilized Worldwide, Canapar, PharmHouse and Solo Growth.  

Jonathan has also been involved in various other domestic cross-border transactions for participants in the cannabis industry, including: various private equity investments for emerging companies; reverse takeover transactions; joint ventures; and acquisitions and investments in companies both in Canada and abroad, including the United States, Italy, Denmark, Poland, Greece, Czech Republic, Colombia, Jamaica, Brazil, Chile, Australia and Lesotho.

Outside of the cannabis industry, Jonathan has advised on transactions in a variety of other industries, including natural resources, real estate, gaming, and other emerging industries such as blockchain and cryptocurrency.

Jonathan is a regular contributor to the Canadian Cannabis and Life Sciences blog. He is also regularly called upon as a thought leader in the cannabis industry speaking at industry events and in publications for The New York Times, The Globe & Mail, Reuters, The Financial Post and MJBizDaily.


  • “Earns high praise for his involvement in the cannabis sector, ‘with this expertise at hand, the business end of things then takes care of itself.’” – Chambers Canada (Cannabis)


Osgoode Hall Law School, J.D.

McGill University, B.Com.

Recent Work

Publications, Newsletters and Articles

A Joint Effort: Nova Scotia Court Certifies Canada’s First Ever Cannabis Product Liability Class Action

Conferences, Speaking Engagements, Events

Jonathan Sherman Speaking on “Cannabis Issues (and Answers) for Real Estate and Business Lawyers” Presented by the Law Society of Ontario

Cassels Brock Hosts Global Cannabis Conference with Eight Capital

Jason Arbuck and Jonathan Sherman Speaking at the Hotel Association of Canada’s National Conference

Proud Sponsor of the OBLS Cannabis Business Law Forum: Featuring Expert Insights by Jamie Litchen and Jonathan Sherman

Proud Sponsor of CHIC 2018: Featuring Expert Insights from Jason Arbuck, Kristin Taylor and Jonathan Sherman

Call to the bar

Ontario, 2015


  • Ontario Bar Association (OBA)


  • Chambers Canada (Cannabis)



Life Sciences

Additional Information

Blog Entries